Alberto Bossi

机构：Université Paris-Saclay, Institut Gustave Roussy, Amethyst Research (United States) · ORCID：0000-0003-3744-7597

发表论文 223 篇 · 总被引 9020 次 · h-index 41

代表论文

Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design (2022 · The Lancet · 被引 828)
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 (2023 · European Journal of Cancer · 被引 167)
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021 (2022 · European Urology · 被引 132)
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 (2022 · European Urology · 被引 123)
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design (2024 · The Lancet · 被引 93)
Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC) (2021 · Biomedicines · 被引 75)